nejm semaglutide cardiovascular New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Semaglutide: The Drug of Today
Description
60% of the weight comes back within a year of stopping GLP-1s
On 2ndDecember 2025, the Delhi High Court declined to grant an interim injunction restraining Dr
Naturally occurs in figs, kiwi, and jackfruit
After two months, there was decrease in weight by 12 kg, body fat percent by 15%, visceral fat by 7%, and a reduction in insulin dose, glycemic variability, and HbA1c
Across studies, fat mass decline predominated, whereas reductions in lean body mass were modest
Fortunately, there are more effective treatments than ever before
